Exicure, Inc. (XCUR)Healthcare | Biotechnology | Redwood City, United States | NasdaqCM
1.65 USD
-0.10
(-5.714%) ⇩
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 2:37 a.m. EDT
The immediate outlook is sharply negative as the stock has lost nearly half its value over the last two weeks, dropping from $2.74 to $1.75, while trading significantly below both its 50-day and 200-day moving averages. This severe technical breakdown, combined with a massive beta of 3.6 indicating extreme volatility, suggests a high probability of further downside in the near term. Looking further ahead, the business fundamentals are deteriorating rapidly; despite a massive one-year price rebound, the company has suffered six consecutive years of negative annual returns, with the most recent drop being a catastrophic 70% decline. The balance sheet is fragile, showing negative free cash flow, negative operating cash flow, and a current ratio below 1.0, which raises serious concerns about liquidity and survival. Finally, there is absolutely no dividend income to offset these risks, making this a pure speculative bet on a turnaround that the current data does not yet support. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.202610 |
| AutoTheta | 0.203299 |
| AutoETS | 0.205723 |
| MSTL | 0.210707 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 27% |
| H-stat | 18.10 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.031 |
| Excess Kurtosis | 0.12 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.049 |
| Market Cap | 10,516,996 |
| Forward P/E | -2.14 |
| Beta | 3.60 |
| Website | https://www.exicuretx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.75106686 |
| Address1 | 400 Seaport Court |
| Address2 | Suite 102 |
| All Time High | 975.0 |
| All Time Low | 1.44 |
| Ask | 2.95 |
| Ask Size | 1 |
| Audit Risk | 10 |
| Average Daily Volume10 Day | 48,710 |
| Average Daily Volume3 Month | 28,255 |
| Average Volume | 28,255 |
| Average Volume10Days | 48,710 |
| Beta | 3.601 |
| Bid | 1.81 |
| Bid Size | 8 |
| Board Risk | 10 |
| Book Value | 0.616 |
| City | Redwood City |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.65 |
| Current Ratio | 0.792 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 1.8 |
| Day Low | 1.65 |
| Debt To Equity | 1.049 |
| Display Name | Exicure |
| Earnings Timestamp End | 1,755,259,200 |
| Earnings Timestamp Start | 1,754,909,940 |
| Ebitda | -8,465,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.937 |
| Enterprise Value | 7,934,996 |
| Eps Forward | -0.77 |
| Eps Trailing Twelve Months | -1.57 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.76348 |
| Fifty Day Average Change | -1.11348 |
| Fifty Day Average Change Percent | -0.40292674 |
| Fifty Two Week Change Percent | -75.10669 |
| Fifty Two Week High | 9.5 |
| Fifty Two Week High Change | -7.85 |
| Fifty Two Week High Change Percent | -0.82631576 |
| Fifty Two Week Low | 1.65 |
| Fifty Two Week Low Change | 0.0 |
| Fifty Two Week Low Change Percent | 0.0 |
| Fifty Two Week Range | 1.65 - 9.5 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,526,995,800,000 |
| Float Shares | 3,547,351 |
| Forward Eps | -0.77 |
| Forward P E | -2.142857 |
| Free Cashflow | -3,878,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 2 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.32814 |
| Held Percent Institutions | 0.02695 |
| Implied Shares Outstanding | 6,373,937 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,724,803,200 |
| Last Split Factor | 1:5 |
| Long Business Summary | Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California. |
| Long Name | Exicure, Inc. |
| Market | us_market |
| Market Cap | 10,516,996 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_82271676 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -9,784,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 10,516,996 |
| Open | 1.77 |
| Operating Cashflow | -8,099,000 |
| Operating Margins | 0.0 |
| Overall Risk | 10 |
| Payout Ratio | 0.0 |
| Phone | 847 673 1700 |
| Previous Close | 1.75 |
| Price Hint | 4 |
| Price To Book | 2.6785715 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.597 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.100000024 |
| Regular Market Change Percent | -5.7142873 |
| Regular Market Day High | 1.8 |
| Regular Market Day Low | 1.65 |
| Regular Market Day Range | 1.65 - 1.8 |
| Regular Market Open | 1.77 |
| Regular Market Previous Close | 1.75 |
| Regular Market Price | 1.65 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 18,635 |
| Return On Assets | -0.32507 |
| Return On Equity | -1.45163 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 6,373,937 |
| Shares Percent Shares Out | 0.0011 |
| Shares Short | 6,731 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 20,834 |
| Short Name | Exicure, Inc. |
| Short Percent Of Float | 0.0022 |
| Short Ratio | 0.15 |
| Source Interval | 15 |
| State | CA |
| Symbol | XCUR |
| Total Cash | 2,604,000 |
| Total Cash Per Share | 0.409 |
| Total Debt | 22,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.57 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.13308 |
| Two Hundred Day Average Change | -2.48308 |
| Two Hundred Day Average Change Percent | -0.600782 |
| Type Disp | Equity |
| Volume | 18,635 |
| Website | https://www.exicuretx.com |
| Zip | 94,063 |